Letermovir (Prevymis)

letermovir · Merck & Co.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Letermovir (Prevymis), covering 2024-11-06 to 2024-11-06. Get the full timeline:

Most recent: Clinical Trial Update: HCMV Breakthrough Infections During Letermovir Prophylaxis [NA]